Yes. One of the design goals of Hillgene's GMP-grade K562 feeder cells is to support large-scale cell therapy production.
Its stable expansion performance, standardized processes, and batch-to-batch consistency make it suitable for applications across the entire workflow, from laboratory research to commercial-scale manufacturing.
View More → Genetically Modified K562 Feeder Cell - Hillgene Biopharma Co., Ltd.